UnknownPhase 2NCT02498782
Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease
Studying American trypanosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Drugs for Neglected Diseases
- Principal Investigator
- Faustino Torrico, MDPlataforma de Antención Integral de Pacientes con Enfermedad de Chagas, Cochabamba, Bolivia
- Intervention
- Fexinidazole(drug)
- Enrollment
- 140 enrolled
- Eligibility
- 18-50 years · All sexes
- Timeline
- 2014 – 2016
Study locations (2)
- Plataforma Atención Integral de Pacientes con Enfermedad de Chagas, Cochabamba, Bolivia
- Plataforma de Atención Integral de Pacientes con Enfermedad de Chagas, Tarija, Bolivia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02498782 on ClinicalTrials.govOther trials for American trypanosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06632600A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.Novartis Pharmaceuticals
- ENROLLING BY INVITATIONNCT07033325University-Based Chagas Testing in Salta Province, ArgentinaMundo Sano Foundation
- RECRUITINGPHASE3NCT04897516Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas DiseaseLaboratorio Elea Phoenix S.A.
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04984265SBRT in Chagas Disease Ventricular TachycardiaUniversity of Sao Paulo General Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT04024163Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas DiseaseInsud Pharma